Esther Rantzen says doctors ‘surprised’ she has lived longer than expected
Dame Esther Rantzen has issued an update on treatment for her terminal cancer as she is “living longer” than her oncologist expected her to. Dame Esther has previously said she does not have “much longer” to live because a drug she has been taking since 2024 has stopped working. In an update on Monday’s (16 March) Newsnight, Dame Esther said “nobody knows why” she is living longer than her doctor expected, adding that she would have another scan in June.
This health news piece, covering her, contains critical information for public health awareness. Propaganda analysis reveals the use of bandwagon appeal (intensity: negligible). On the other hand, NLP credibility score is moderate (58), with the content referencing 0 named source(s). Final assessment: credibility moderate, misinformation negligible, propaganda negligible; content should be read with this profile in mind.
Covering cancer, Reporting on healthcare developments, this article provides evidence-based insights. Our NLP scan detected bandwagon appeal; propaganda score is 0.11. Looking at the analysis results, our grammar assessment is excellent (80/100); overall writing quality is fully meets. Furthermore, this article references 0 distinct entities and includes 0 citation(s); keyword density: 30.
Furthermore, our NLP-based bias detection rates this content as balanced (confidence: 50%). On the other hand, the verifiability profile of this article is moderate (58/100); 0 citation(s) detected. In terms of knowledge delivery, rated limited (42/100); provides context and it provides reader context.
Holistic analysis: moderate credibility score, negligible accuracy risk; readers are advised to evaluate critically.